Vitamin D affects how your immune system works, and plays a role in controlling certain types of inflammation, including the ...

But in reality, “most of us get just a fraction of that,” she says. That’s where multivitamins come in — to fill in nutrient gaps. As registered dietitian and founder of Chelsea Nutrition ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, it’s a busy ...

A complete multivitamin can help fill the gap, especially when specifically formulated for your age bracket. It also provides lutein, a carotenoid antioxidant that supports brain and eye function.

Vitamin D regulates the amount of calcium and phosphate in the ... CC reports personal fees from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, and Takeda, outside ...

If the recent time change and darker days have you feeling drained and like you want to crawl back into bed, you may want to consult your doctor about taking vitamins for energy. Unsurprisingly ...

June 3, 2024 — Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require ...

GSK has stopped (PDF) development of one of the lead programs from its $2.1 billion Affinivax takeover, axing a phase 2 pneumococcal 24-valent vaccine candidate for adults in favor of a ...

Taylor Leamey writes about all things wellness, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...

LONDON — GSK’s once-booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year. Notably, quarterly sales of the ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.